Long-acting HIV prevention reaches public-health scale
Long-acting HIV prevention moves from product availability to generic or publicly financed delivery at multi-country scale.
Shared claim
Long-acting HIV prevention moves from product availability to generic or publicly financed delivery at multi-country scale.
Timing assessment
The forecasts are one year apart, in 2027 and 2028.